Myocarditis: Diagnosis, Prognosis and Management
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 1958
Special Issue Editors
Interests: inflammatory cardiomyopathy; dilated cardiomyopathy; myocarditis; hypertrophic cardiomyopathy; arrhythmogenic cardiomyopathy; heart failure; personalized medicine; endomyocardial biopsy; viral myocardial infection
Interests: cardiac magnetic resonance; echocardiography; cardiomyopathies; inflammatory cardiomyopathy; heart failure; myocarditis; biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Myocarditis is an inflammatory heart disease induced by infectious or non-infectious causes, frequently triggering immune-mediated pathologic mechanisms, leading to myocardial structural and functional compromise. Due to the large variability of clinical presentation, the unpredictable course of the disease, and the lack of established causative treatments, myocarditis is a major diagnostic and therapeutic challenge in cardiology. Furthermore, an increasing incidence of myocarditis has been observed in recent decades.
Recent years have seen important progress in available non-invasive diagnostic methods, including biomarkers, serum anti-heart autoantibodies, microRNAs, speckle tracking echocardiography, cardiac magnetic resonance T1 and T2 tissue mapping, and positron emission tomography, which may help to distinguish the underlying pathogenesis and refine the diagnostic workup of myocarditis. However, endomyocardial biopsy is still the diagnostic gold standard.
Nevertheless, there is a significant knowledge gap regarding the pathogenesis of myocarditis, as well as individualized diagnostic and treatment concepts. In particular, new biomarkers, and disease-specific diagnostic and therapeutic strategies are required to adequately manage patients with suspected myocarditis. It is also increasingly recognized that personalized management should also include the implementation of disease-specific therapies.
For this Special Issue, we encourage the submission of manuscripts on any aspects of the pathophysiologic mechanisms, diagnosis (such as novel biomarkers, advances in cardiac imaging modalities, and endomyocardial biopsy), and treatment of myocarditis, including experimental, translational, and clinical research. We accept reviews, short communications, methodology papers, and full-size research papers with a focus on the following aspects:
- Novel effective diagnostic and/or therapeutic strategies for myocarditis;
- Approaches to better classify the phenotypes and/or etiologies of myocarditis;
- New genes, pathomechanisms, and potential drug targets for a particular phenotypes and/or etiologies of myocarditis.
Dr. Krzysztof Ozierański
Dr. Agata Tymińska
Prof. Dr. Arsen D. Ristić
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- myocarditis
- inflammatory cardiomyopathy
- dilated cardiomyopathy
- heart failure
- immunosuppressive treatment
- myocardial inflammation
- personalized medicine
- endomyocardial biopsy
- viral myocardial infection
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
